Fundz

Formation Bio Appoints Michael D. Ehlers as Chief Scientific Officer

PRIVATEJul 22, 2026

Position

Chief Scientific Officer

Company

Formation Bio

Michael D. Ehlers
New YorkBiotechnologyHealth CareArtificial IntelligencePharmaceutical

Description

Formation Bio has announced the appointment of Michael D. Ehlers, MD, PhD, as the Chief Scientific Officer and Head of Research & Development. Ehlers will lead the scientific and clinical strategy, overseeing portfolio advancements from translational sciences through clinical development.

Other recent leadership changes in Pharmaceutical and Biotechnology

Executive moves at companies in the same sectors within 45 days, from Fundz verified event records.

Who to call at Formation Bio, and when

A new leader at Formation Bio brings new priorities and often new vendors. The first weeks are when they listen.

  • An alert the day Formation Bio raises, hires an executive or expands, scored against what you sell
  • The decision-makers there, with verified emails
  • Who you already know at Formation Bio, from your own LinkedIn network

Works inside ChatGPT and Claude. Ask who to call at Formation Bio. With Fundz connected, it knows.

Watch Fundz in
See plan options
Trusted byOracleSnowflakeCloudflareLinkedInGoogleSalesforce 4.8/5 on G2

Company Information

Company

Formation Bio

Location

New York, New York, United States

About

TrialSpark, a tech-driven drug developer with a portfolio of clinical stage drug assets, is rebranding to Formation Bio. Formation Bio is a tech-driven pharmaceutical company differentiated by radically more efficient drug development. Formation Bio has built a technology platform that optimizes critical aspects of clinical drug development, enabling more efficient trial design, faster trial completion, and higher quality trial data. The company acquires clinical-stage drugs from pharmaceutical and biotech companies with the goal to develop them faster in order to accelerate access to new treatments for patients, and to unlock greater value per program.

AI made execution free. Knowing first is the whole game now.

Fundz sees it the moment Formation Bio changes its leadership, hires an exec or expands, usually minutes after it happens, and tells you who to reach.

Related People

Linhao
Likely contact at this company
••••••••@••••••••

See Linhao's verified email →

Emily
Senior decision-maker at this company
••••••••@••••••••

See Emily's verified email →

Create an account to reveal verified emails
Predictive Intelligence
Strategic

ML-powered predictions for Formation Bio's next move

Learn about Strategic plan

Formation Bio changed its leadership. Fundz had it the day it was filed, with the decision-maker at the company attached.

145 of these a day, filtered to the companies you pick, with the decision-maker attached.

5 screens from a live account. No signup.

Fundz is a real-time business intelligence platform powered by agentic AI that proactively delivers personalized daily signals, including funding rounds, executive changes, M&A activity, 13F institutional filings, SEC 8-K events, investor activity, and website modifications, based on each user's watchlist and ICP. A trusted data source at firms such as BlackRock, Oracle, Kleiner Perkins, LinkedIn, HubSpot, and Cloudflare, Fundz democratizes the institutional-grade intelligence that previously required a PitchBook or Bloomberg terminal. Features include Daily Briefing for AI-powered daily briefings, and unified cross-signal alerts across 281,000+ organizations. Developers and data teams can access these signals programmatically via the Fundz Funding Data API, with transparent published pricing.